Aims: To explore the feasibility of quantitative evaluation of pulmonary function in patients with chronic obstructive pulmonary disease (COPD) using tissue velocity imaging (TVI) and strain rate imaging (SRI) via transthoracic lung ultrasonography. Material and methods: Eighty inpatients with clinically diagnosed COPD underwent pulmonary function test and transthoracic lung ultrasound on the same day. Lung ultrasound variables and pulmonary function parameters were analyzed. Results: All patients with COPD had faster breathing and significant reduced lung function compared with healthy participants (p<0.05). The lung ultrasound parameters, velocity (max-min, cm/s), displacement (max-min, mm), strain (max-min, %) and strain rate (max-min, 1/s) were significantly higher in patients with COPD (p<0.05). A good negative correlation was found between lung ultrasound variables and pulmonary function parameters in patients with COPD. Stepwise multiple regression analysis indicated that the velocity (max-min, cm/s) was the only independent determinant of FEV1/FVC (%). With the use of FEV1/FVC<70% as the criteria of irreversible pulmonary function impairment to distinguish an abnormal pulmonary function, the area under the ROC was 0.99 for the velocity (max-min, cm/s) of the lung tissue in the process of breathing. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the cut off value (1.19 cm/s) was 97.63%, 100%, 100%, 80%, and 98%, respectively (p<0.001). Conclusions: Tissue velocity imaging via transthoracic lung ultrasound is a useful modality in the assessment of pulmonary function in patients with COPD.
Introduction
Pulmonary function testing plays an important role in the assessment of disease severity, functional disability, disease activity, and response to treatment, particularly with regard to diseases such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease [1] . However, pulmonary function testing requires cooperation between the subjects and the examiner, and the results obtained depend on technical as well as personal factors [2] . Alternative and noninvasive techniques which do not require the patient's cooperation during spontaneous breathing are required.
In the past two decades, tissue velocity imaging (TVI) and strain rate imaging (SRI) have been used in the quantitative evaluation of myocardial function and this has been a recommended component of routine echocardiography [3, 4] . However, whether TVI and SRI can quantify pulmonary function remains unknown. The objective of this study was to evaluate the value of TVI and SRI in the assessment of pulmonary function and to compare them with the results of pulmonary function testing in patients with COPD. Measurement of lung velocity, displacement, strain and strain rate: a) the maximal velocity and minimal velocity determined by tissue velocity imaging; b) the maximal displacement and minimal displacement determined by using tissue velocity imaging; c) the maximal strain and minimal strain determined by strain imaging; d) the maximal strain rate and minimal strain rate determined by strain rate imaging. [5, 6] . The study was approved by the local Ethics Committee of Yancheng (No.2014052), and free informed consent was obtained from all the subjects. The pulmonary function test and transthoracic lung ultrasound were performed on the same day.
Material and methods

Study population
Pulmonary function test
Standard spirometry were performed in all patients by means of a fully equipped computerized system (Cosmed SrL, Quark PFTs ergo, P/N Co9035 -12-99, Italy) for measurement of FEV1, FVC, FEV1/FVC, total lung capacity (TLC), tidal volume (VT), maximal voluntary ventilation (MVV), expiratory reserve volume (ERV), vital capacity (VC), peak expiratory flow (PEF), forced expired flow at 25% of FVC (FEF 25%), and volume backextrapol % FVC.
Transthoracic lung ultrasound
All the patients underwent transthoracic examination using a commercially available Vivid E9 ultrasound machine (GE Healthcare, Horten, Norway) equipped with a M5S single-crystal matrix-array transducer and Q-analyze quantitative analysis software for the analysis of TVI and SRI. The scanning was performed by two experienced operators with 20 years experience in lung ultrasonography and echocardiography who were blinded to all clinical data and previous reading. The intercostal spaces were used as acoustic windows. Patients were placed in a sitting position raising their arms above the head to widen the intercostal space and facilitate scanning. First of all, the TVI and SRI function were activated, and the dynamic images of three respiratory cycles in four chest zones (the upper anterior zone, the lower anterior zone, the upper lateral zone, and the basal lateral zone) per side were stored at a frame rate of 50 frames per second for subsequent analysis. Then, a region of interest was placed at each zone. The maximal velocity, minimal velocity, maximal displacement, minimal displacement, maximal strain, minimal strain, maximal strain rate and minimal strain rate during the process of breathing were measured (fig 1) . The difference between maximal and minimal velocity (V, max-min, cm/s), the difference between maximal and minimal displacement (D, max-min, mm), the difference between maximal and minimal strain (St, max-min, %) and the difference between maximal and minimal strain rate (SR, max-min, 1/s) were calculated. Each variable per zone was obtained by averaging measurements from three successive respiratory cycles, and each variable in all zones was also obtained by averaging measurements from all zones.
Echocardiography
A complete bidimensional and Doppler study was performed in all subjects using the ultrasound scanner mentioned above. Patients were placed in the left lateral decubitus position and standard parasternal and fourchamber apical views were obtained by two independent operators (above mentioned). The pulmonary artery systolic pressure (PASP) was estimated by adding the right atrial pressure to the transtricuspid pressure gradient in the absence of right ventricular outflow obstruction [7, 8] . The transtricuspid pressure gradient was calculated from the peak tricuspid regurgitation velocity using the modified Bernoulli equation. Measurement of cardiac morphology and function indicators included: left atrial end-systolic anteroposterior diameter (LA), left ventricular end-diastolic anteroposterior diameter (LV), right atrial end-systolic transverse diameter (RA), right ventricular end-diastolic anteroposterior diameter (RV), tricuspid annular plane systolic excursion (TAPSE), left ventricular ejection fraction (LVEF). All values for each parameter were obtained by averaging measurements from three successive cardiac cycles.
Statistical analysis
Results in this study are expressed as mean ± standard deviation or number and percentage. The differences between the two groups were tested using an unpaired two tailed t test. The correlation between different parameters was performed using the Pearson test. A receiver operating characteristic curve (ROC) analysis was used to predict irreversible pulmonary function impairment and to determine the optimal cut-off points and validity parameters. A value of p<0.05 was considered statistically significant. All statistical analyses were performed with SPSS version 16 software for Windows (SPSS Inc, Chicago, IL).
Results
Baseline characteristics
As shown in Table I , all patients with COPD had faster breathing and heartbeat, shortened six minutes walking distance, larger right atrial and ventricular size, increased pulmonary artery systolic pressure, significant reduced lung function and TAPSE compared with healthy participants (p<0.01 or p<0.05), while the lung ultrasound variables, V (max-min, cm/s), D (max-min, mm), St (max-min, %), and SR (max-min, 1/s) were all significantly higher in patients with COPD comparing with healthy participants. No significant differences were found between the two groups with regard to age, male ratio, left atrial and ventricular size ,as well as LVEF (p >0.05).
Comparison of the lung ultrasound variables among different chest zones
As shown in Table II , there were no significant differences among different chest zones with regard to the lung ultrasound variables, V (max-min, cm/s), D (max-min, mm), St (max-min, %) and SR (max-min, 1/s) (p >0.05). Correlation between lung ultrasound variables and pulmonary function parameters in patients with COPD As shown in Table III , a good negative correlation could be found between lung ultrasound variables and pulmonary function parameters in patients with COPD. The V (max-min, cm/s), D (max-min, mm), St (max-min, %), and SR (max-min, 1/s) significantly correlated with FEV1/FVC (%) (p<0.001), while the V (max-min, cm/s) significantly correlated with all the pulmonary function parameters: VT(%), MVV(%), ERV(%), FEV1/FVC(%), TLC(%), FEF25(%), PEF(%), volume backextrapol %FVC. However, no lung ultrasound variables were associated with pulmonary function parameters.
Multiple regression analysis
As shown in Table IV the multiple regression analysis (stepwise method) indicated that V (max-min, cm/s) was an independent determinant of FEV1/FVC (%).
ROC analysis
At FEV1/FVC<70% (as criteria of irreversible pulmonary function impairment) the area under the ROC was 0.99 (95% confidence interval: 0.98 to 1.01) for V (max-min, cm/s) of the lung tissue in the process of breathing. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the cut off value (1.19 cm/s) was 97.63%, 100%, 100%, 80%, and 98%, respectively (p<0.001).
Inter/intra observer variability Intra observer and inter observer agreement in the measurement of lung ultrasound variables were fairly good: intraclass correlation coefficient (ICC) was 0.92 (0.71-0.97), 0.93 (0.75-0.98) for inter and intra observer, respectively. Inter and intra observer agreement in the measurement of pulmonary function parameters, were still good: ICC was 0.93 (0.67-0.98), 0.93 (0.71-0.99) for inter and intra observer, respectively.
Discussions
The results of our study indicate that transthoracic lung ultrasound can effectively detect the pulmonary function changes, and the increased difference between maximal and minimal velocity obtained at tissue velocity imaging is a sensitive and specific predictor of pulmonary function impairment in patients with COPD.
Recently, the COPD diagnostic criteria based on spirometry test (FEV1/ FVC < 70%) has been questioned, and many factors, such as age, race, gender, or BMI were related with FEV1/ FVC [9] [10] [11] . In addition, pulmonary function testing requires good laboratory quality assurance, highly motivated and well-trained physicians and technologists. Therefore, it is necessary to explore simple, new, and better ways of improving patient outcomes. TVI and SRI maturation, which have been developed to quantify myocardial velocity, deformation and deformation rate, respectively, just open an interesting window into the lung tissue movement mechanics. However, the lung is one of the major body organs, and there is no unified standard for the choice of the acoustic window. In our study, we borrowed from the methods described by Gargani et al [12] and Volpicelli et al [13] namely, eight chest zones, four chest zones (the upper anterior zone, the lower ante- Table III . Linear correlation analysis for pulmonary function and lung ultrasound variables in patients with chronic obstructive pulmonary disease. rior zone, the upper lateral zone and the basal lateral zone) per side. Surprisingly, we found there were no significant differences among different chest zones with regard to the lung ultrasound variables in patients with COPD. COPD is characterized by irreversible chronic airflow limitation that is caused by emphysematous destruction of lung elastic tissue and/or obstruction in the small airways due to occlusion of their lumen by inflammatory mucus exudates, narrowing and obliteration [14] . In our study, we found that all patients with COPD had faster breathing, increased difference between maximal and minimal velocity, displacement, stain, and stain rate. We think these findings resulted from the compensatory effects of the respiratory muscle, and TVI and SRI actually reflected a passive movement of lung tissue. We also found a good negative correlation between lung ultrasound variables and pulmonary function parameters in patients with COPD, the worst pulmonary function, the greater difference between maximal and minimal velocity, displacement, stain, and stain rate. Through the statistical analysis, we confirmed that the difference between maximal and minimal velocity was the only independent determinant of FEV1/FVC, with a good diagnosis performance for pulmonary function impairment (FEV1/ FVC<70%) at a cut off value of 1.19cm/s. This study had some limitations. Firstly, lung ultrasound is an operator-dependent method and there is a lack of unified criteria to perform this examination more precisely. Secondly, the lung tissue movement characteristics expressed with TVI and SRI need to be further interpreted. Thirdly, the patient population examined was limited. New data need to be collected in subsequent studies.
Variables
Conclusions
This is the first study on evaluating the feasibility of transthoracic lung ultrasound in the assessment of pulmonary function in patients with COPD. Our study demonstrates that the increased difference between maximal velocity and minimal velocity obtained tissue velocity imaging is a sensitive and specific predictor of pulmonary function impairment in patients with COPD. Although there are some limitations mentioned above, this method still holds considerable clinical promise for the assessment of pulmonary function.
